Constant rate infusion of vancomycin in premature neonates: a new dosage schedule

被引:40
作者
Pawlotsky, F
Thomas, A
Kergueris, MF
Debillon, T
Roze, JC
机构
[1] CHU Nantes, Hop Mere & Enfant, Unite Reanimat Neonatol, F-44035 Nantes 05, France
[2] CHU Nantes, Hotel Dieu, Pharmacol Unit, F-44035 Nantes, France
关键词
vancomycin; pharmacokinetics; continuous rate infusion; premature infants;
D O I
10.1046/j.1365-2125.1998.00763.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Since vancomycin's bactericidal action has been shown to be time-dependent, a constant rate infusion over 24 h might result in a better bactericidal efficacy. The purpose of this study was to define a new dosage schedule in prematures. Methods Two vancomycin 24 h constant rate infusion schedules were tested in two groups of neonates. Postconceptional age (PCA) was 27 to 41 weeks in group 1 (n=24) and 28 to 51.5 weeks in group 2 (n=29). Group 1 neonates received continuous infusion of 10 to 30 mg kg(-1) day(-1), adjusted for PCA and weight. Group 2 was designed to take into account the significant relationship observed in group 1 between vancomycin clearance standardized on weight and PCA and consisted of a constant loading dose of 7 mg kg(-1) followed by continuous infusion of 10 to 40 mg kg(-1) day(-1) adjusted for PCA and weight. Results Mean vancomycin serum concentration at steady state was 11+/-3.1 mg l(-1) in group 1 and 15.4+/-6.2. mg l(-1) in group 2. Fifty-six percent of group 1 values vs 88% of group 2 values were between 10 and 30 mg(-1) at steady state (P<0.01). Both regimens were well tolerated. Conclusion A loading dose of vancomycin followed by constant rate infusion of the appropriate dose adjusted for PCA and weight might improve vancomycin concentrations in neonates.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 31 条
[1]   ANALYSIS OF VANCOMYCIN TIME-KILL STUDIES WITH STAPHYLOCOCCUS SPECIES BY USING A CURVE STRIPPING PROGRAM TO DESCRIBE THE RELATIONSHIP BETWEEN CONCENTRATION AND PHARMACODYNAMIC RESPONSE [J].
ACKERMAN, BH ;
VANNIER, AM ;
EUDY, EB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1766-1769
[2]   COMPARISON OF THE ACTIVITIES OF COUMERMYCIN, CIPROFLOXACIN, TEICOPLANIN, AND OTHER NON-BETA-LACTAM ANTIBIOTICS AGAINST CLINICAL ISOLATES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS FROM VARIOUS GEOGRAPHICAL LOCATIONS [J].
ALDRIDGE, KE ;
JANNEY, A ;
SANDERS, CV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :634-638
[3]   VANCOMYCIN-ASSOCIATED SHOCK IN NEONATES [J].
ANGLADA, AM ;
CERNADAS, JMC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (01) :104-105
[4]  
ASBURY WH, 1993, ANN PHARMACOTHER, V27, P490
[5]  
BAROIS A, 1986, PRESSE MED, V15, P1805
[6]  
BORDERON JC, 1994, PATHOL BIOL, V42, P525
[7]  
Das Gupta V, 1986, Am J Hosp Pharm, V43, P1729
[8]   ANTISTAPHYLOCOCCAL ACTIVITY OF TEICOPLANIN, VANCOMYCIN, AND OTHER ANTIMICROBIAL AGENTS - THE SIGNIFICANCE OF METHICILLIN RESISTANCE [J].
DELBENE, VE ;
JOHN, JF ;
TWITTY, JA ;
LEWIS, JW .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02) :349-352
[9]  
DUFFULL SB, 1994, ADVERSE DRUG REACT T, V13, P103
[10]   SUSCEPTIBILITY AND SYNERGY STUDIES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-EPIDERMIDIS [J].
EIN, ME ;
SMITH, NJ ;
ARUFFO, JF ;
HEEREMA, MS ;
BRADSHAW, MW ;
WILLIAMS, TW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :655-659